Serina Therapeutics SER
NYSE SER
$2.43 -0.14 (-5.36%)
As of: Sep 10, 2026 · 3:59 PM EDT

Serina Therapeutics (SER) Preferred Shares (2018 - 2025)

Serina Therapeutics' (SER) quarterly Preferred Shares came in at $4.9 million in Q4 2025, little changed quarter-over-quarter from $4.9 million in Q3 2025.

Analysis

Serina Therapeutics (SER) Preferred Shares (2018 - 2025) Analysis & Trends

Serina Therapeutics has disclosed Preferred Shares across 4 years of filings, most recently posting $4.9 million for Q4 2025.

  • In Q4 2025, Preferred Shares changed N/A year-over-year to $4.9 million; the TTM figure through Dec 2025 stood at $4.9 million (changed N/A YoY), while the FY2025 annual figure was $4.9 million, changed N/A from the prior year.
  • Preferred Shares came in at $4.9 million for Q4 2025 at Serina Therapeutics, roughly flat from $4.9 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $5.0 million in Q1 2024 to a low of $4.9 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Serina Therapeutics 40.47 Mn 17.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.94 Mn
Sep 30, 2025 4.94 Mn
Jun 30, 2025 4.94 Mn
Mar 31, 2024 5.00 Mn
Mar 31, 2019 5.00 Mn
Dec 31, 2018 5.00 Mn